PubRank
Search
About
W F Carman
Author PubWeight™ 72.73
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients.
J Infect Dis
1997
3.39
2
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region.
Hepatology
2001
2.30
3
Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire.
BMJ
1996
2.01
4
Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactions.
J Clin Virol
2005
1.86
5
Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective.
J Gastroenterol Hepatol
1999
1.54
6
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients.
J Clin Virol
2003
1.53
7
Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.
Hepatology
2000
1.50
8
Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic.
Sex Transm Infect
2002
1.49
9
BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen.
Transpl Infect Dis
2010
1.40
10
Determinants of universal adolescent hepatitis B vaccine uptake.
Arch Dis Child
2004
1.37
11
Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years.
BMJ
2002
1.37
12
Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10.
Euro Surveill
2010
1.34
13
Costs of running a universal adolescent hepatitis B vaccination programme.
Vaccine
2005
1.21
14
Practical experience of high throughput real time PCR in the routine diagnostic virology setting.
J Clin Virol
2006
1.21
15
Influenza diagnosis: from dark isolation into the molecular light. West of Scotland Respiratory Virus Study Group.
J Infect
1999
1.18
16
Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays.
Hepatology
2000
1.16
17
Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin.
J Viral Hepat
2009
1.14
18
2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak.
Euro Surveill
2010
1.13
19
HBV core sequence: definition of genotype-specific variability and correlation with geographical origin.
J Viral Hepat
2004
1.11
20
Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
Vaccine
2004
1.10
21
Nosocomial transmission of influenza.
Occup Med (Lond)
2002
1.07
22
Use of PCR in resolving diagnostic difficulties potentially caused by genetic variation of hepatitis B virus.
J Clin Pathol
1998
1.05
23
T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients.
Liver
1999
1.04
24
The clinical significance of molecular variation within the hepatitis B virus genome.
Hepatology
1992
1.02
25
Norwalk like virus by light cycler PCR.
J Clin Virol
2002
0.99
26
Hepatitis B virus precore/core variation and interferon therapy.
Hepatology
1995
0.99
27
Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care.
Age Ageing
1999
0.98
28
Using multiplex real time PCR in order to streamline a routine diagnostic service.
J Clin Virol
2008
0.98
29
A multi-centre pilot proficiency programme to assess the quality of molecular detection of respiratory viruses.
J Clin Virol
2005
0.97
30
Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus.
J Virol Methods
2009
0.96
31
Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes.
J Med Virol
2004
0.94
32
The predicted pattern of emergence of vaccine-resistant hepatitis B: a cause for concern?
Vaccine
1999
0.94
33
Importance of PCR in the diagnosis and understanding of rotavirus illness in the community.
Commun Dis Public Health
2003
0.93
34
HGV: the identification, biology and prevalence of an orphan virus.
Liver
1998
0.93
35
Current status of HBV vaccine escape variants--a mathematical model of their epidemiology.
J Viral Hepat
1998
0.93
36
The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants.
Vaccine
2001
0.90
37
Population exposure to a novel influenza A virus over three waves of infection.
J Clin Virol
2011
0.89
38
Comparison of real-time PCR and EIA for the detection of outbreaks of acute gastroenteritis caused by norovirus.
Commun Dis Public Health
2003
0.89
39
Predictions of the emergence of vaccine-resistant hepatitis B in The Gambia using a mathematical model.
Epidemiol Infect
2000
0.86
40
Clinical implications of hepatitis B virus envelope protein variation.
Int J Clin Lab Res
1994
0.86
41
Universal hepatitis B vaccination of UK adolescents: a feasibility and acceptability study.
Commun Dis Public Health
2002
0.86
42
Emergence of a new norovirus variant in Scotland in 2006.
J Clin Microbiol
2007
0.85
43
Comparison of two real-time PCR methods for diagnosis of norovirus infection in outbreak and community settings.
J Clin Microbiol
2005
0.84
44
Envelope and precore/core variants of hepatitis B virus.
Gastroenterol Clin North Am
1994
0.83
45
Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain.
J Infect Dis
1994
0.83
46
Hepatitis B virus: origin and evolution.
J Viral Hepat
2009
0.83
47
The real-time detection of sapovirus.
J Clin Virol
2006
0.83
48
An efficient extraction method from blood clots for studies requiring both host and viral DNA.
J Viral Hepat
2000
0.83
49
Influenza A(H1N1)2009 antibody seroprevalence in Scotland following the 2010/11 influenza season.
Euro Surveill
2011
0.82
50
Selection of hepatitis B surface "escape" mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function.
Gut
1999
0.82
51
The hepatitis B virus.
Baillieres Clin Gastroenterol
1990
0.82
52
Transmission of hepatitis B virus from a vaccinated healthcare worker.
J Hosp Infect
2007
0.82
53
Blastomyces dermatitidis infections in the RSA.
S Afr Med J
1989
0.81
54
First rotavirus, now astrovirus: the evolving benefits of RT-PCR.
Commun Dis Public Health
2003
0.81
55
Failed adoptive immunity transfer: reactivation or reinfection?
J Viral Hepat
1999
0.80
56
Effect of cyclosporin-A in woodchucks with chronic hepatitis delta virus infection.
J Med Virol
1992
0.80
57
Simultaneous detection and quantitation of cytomegalovirus, Epstein-Barr virus, and adenovirus by use of real-time PCR and pooled standards.
J Clin Microbiol
2009
0.79
58
Life-threatening human metapneumovirus infections in West of Scotland.
J Clin Virol
2007
0.78
59
The host immune response may be responsible for selection of envelope and precore/core variants of HBV.
Prog Liver Dis
1992
0.78
60
Transmission of a homogenous hepatitis B virus population of A1896-containing strains leading to mild resolving acute hepatitis and seroconversion to hepatitis B e antigen antibodies in an adult.
Hepatology
1997
0.77
61
Contamination with PCR detectable virus in a virus isolation quality assurance panel.
J Virol Methods
2006
0.77
62
Further characterization of 2 types of precore variant hepatitis B virus isolates from Hong Kong.
J Infect Dis
1995
0.77
63
The host immune response may be responsible for selection of envelope and precore/core variants of HBV.
J Hepatol
1991
0.76
64
Hepatitis B and health care workers.
Lancet
1997
0.76
65
Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B.
J Hepatol
1998
0.76
66
Age related prevalence of hepatitis G virus in South Africans.
J Clin Pathol
1999
0.76
67
Influenza in old age.
Age Ageing
2001
0.76
68
Detection of hepatitis B virus DNA sequences in liver in HBsAg seronegative patients with liver disease with and without anti-HBc antibodies.
Q J Med
1991
0.75
69
Hospital transmission of hepatitis B virus in the absence of exposure prone procedures.
Epidemiol Infect
2006
0.75
70
Recombinant vaccinia viruses expressing hepatitis A virus structural polypeptides: detection of an anti-VP0 response in convalescent-phase sera.
Clin Diagn Lab Immunol
1995
0.75
71
Microneutralisation assays for the detection of 2009 pandemic influenza A(H1N1) antibodies: a comparative test of serum and plasma.
J Clin Virol
2010
0.75
72
The effectiveness of national influenza vaccination policies for at-risk populations over 5 seasons in a Scottish general practice.
Vaccine
2008
0.75
73
Replication of hepatitis B and delta viruses: appearance of viral mutants.
Semin Liver Dis
1991
0.75
74
An unidentified hepatitis B virus carrier on a haemodialysis unit: management and outcome.
J Hosp Infect
2001
0.75
75
Antiviral prophylaxis and treatment (excluding HIV therapy).
J Clin Virol
2002
0.75
76
Hepatitis viruses.
Baillieres Clin Gastroenterol
1990
0.75
77
Avoiding errors in the molecular epidemiological analysis of hepatitis B virus transmission incidents.
J Clin Virol
2005
0.75